Kolon Life Science Incorporation operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kolon Life Science Incorporation with three other
companies in this sector in South Korea:
Kyongbo Pharmaceutical Co Ltd
sales of 186.73 billion Korean Won [US$165.07 million]
of which 100%
was Drugs & Pharmaceutical Raw Materials),
(158.60 billion Korean Won [US$140.20 million]
of which 91%
was Medicine), and
(139.44 billion Korean Won [US$123.26 million]
During the year ended December of 2016, sales at
Kolon Life Science Incorporation were 158.28 billion Korean Won (US$139.92 million).
increase of 30.6%
versus 2015, when the company's sales were 121.18 billion Korean Won.
Sales of Environment Material saw an increase
that was more than double the company's growth rate: sales were up
83.3% in 2016, from
38.49 billion Korean Won to 70.57 billion Korean Won.